Source disclosure: February 13, 2026
Ezaki Glico Co.,Ltd. [2206.T]
TOKYO, Feb 13 (Pulse News Wire) – Ezaki Glico CO.,LTD. (2206.T) reported an impairment loss of ¥3.393 billion in its fiscal fourth quarter ended December 31, 2025.
The impairment charge was recorded due to a reassessment of the future recoverability of assets related to its infant formula milk business within the dairy division. Considering the current business environment and future outlook, the company determined that the carrying value of certain fixed assets should be reduced to their recoverable amount based on accounting standards for asset impairments.
This special loss has been reflected in the company’s consolidated earnings report released today for the fiscal year ending December 31, 2025.
AI-translated content. 🟢 Confidence: High See terms • Original filing